186
Views
0
CrossRef citations to date
0
Altmetric
Review

Predicting quality of life outcomes in children with migraine

Pages 291-299 | Received 28 Dec 2021, Accepted 07 Mar 2022, Published online: 15 Mar 2022

References

  • Abu-Arafeh I, Russell G. Prevalence of headache and migraine in schoolchildren. BMJ. 1994;309(6957):765–769.
  • Abu-Arafeh I, Razak S, Sivaraman B, et al. The prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies. Dmcn. 2010;52:1088–1097.
  • Classification subcommittee of the International Headache Society. International Classification of Headache Disorders-3rd edition, Cephalalgia, 2018,38:1–211
  • Ozge A, BSasmaz T, Bugdayci, SE, et al. The prevalence of episodic and chronic migraine in children and adolescents. Eur J Neurol. 2013;20(1):95–101.
  • Özge A, Abu-Arafeh I, Gelfand AA, et al., Experts’ opinion about the secondary headache diagnostic criteria of the ICHD-3rd edition beta in children and adolescents. J Headache Pain. 18(1): 113. 2017.
  • Valeriani M, Abu-Arafeh I, Ozge A. Clinical and pathophysiological peculiarities of headache in children and adolescents. Front Neurol. 2019,10:1280.
  • Abu-Arafeh I, Gelfand AA. The childhood migraine syndrome. Nat Rev Neurol. 2021;17(7):449–458.
  • Ashina M, Terwindt GM, Al-Karagholi MA, et al. Migraine: disease characterisation, biomarkers, and precision medicine. Lancet. 2021;397(10283):1496–1504.
  • Burstein R, Noseda R, Borsook D. Migraine: multiple processes, complex pathophysiology. J Neurosci. 2015;35(17):6619–6629.
  • Goadsby PJ, Holland PR, Martins-Oliveira M, et al., Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev. 97(2): 553–622. 2017.
  • BIBN 4096 BS Clinical Proof of Concept Study Group, Olesen J, Diener HC, Husstedt IW, et al. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med. 2004;350(11):1104–1110.
  • Fan PC, Kuo PH, Lee MT, et al. Plasma calcitonin gene-related peptide: a potential biomarker for diagnosis and therapeutic responses in pediatric migraine. Front Neurol. 2019;10. https://doi.org/10.3389/fneur.2019.00010. PMID: 30733702; PMCID: PMC6353836.
  • Guarnea A, Bottino F, Napolitano A, et al. Early alteration of cortical thickness and gyrification in migraine without aura: a retrospective MRI study in pediatric patients. J Headache Pain. 2021;22(1):79, PMD–34294048.
  • BellT KA, Stokoe M, Stokoe M, et al. Age-related differences in resting state functional connectivity in pediatric migraine. J Headache Pain. 2021;22(1):65. PMID 34229614.
  • Hanci F, Kilinc YB, Kilinc E, et al. Plasma levels of vasoactive neuropeptides in pediatric patients with migraine during attack and attack-free periods. Cephalalgia. 2021;41(2):166–175.
  • Aromaa M, Rautava P, Helenius H, et al. Factors of early life as predictors of headache in children at school entry. Headache. 1998;38(1):23–30.
  • Guidetti V, Cerutti R, Faedda N, et al., Migraine in childhood: an organic, biobehavioral, or psychosomatic disorder? Neurol Sci. 40(S1): 93–98. 2019.
  • Abu-Arafeh I, Hershey AD, Diener H-C, et al. Guidelines of the international headache society for controlled trials of preventive treatment of migraine in children and adolescents, 1st edition, Cephalalgia, 2019,39:803–816
  • Bieri D, Reeve RA, Champion GD, et al. The faces pain scale for the self-assessment of the severity of pain experienced by children: development, initial validation, and preliminary investigation for ratio scale properties. Pain. 1990;41(2):139–150.
  • Ripamonti CI, Brunelli C. Comparison between numerical rating scale and six-level verbal rating scale in cancer patients with pain: a preliminary report. Support Care Cancer. 2009;17(11):1433–1434.
  • Stafstrom CE, Goldenholz SR, Dulli DA. Serial headache drawings by children with migraine: correlation with clinical headache status. J Child Neurol. 2005;20(10):809–813.
  • Mazzotta S, Pavlidis E, Cordori C, et al. Children’s headache: drawings in the diagnostic work up. Neuropediatrics. 2015;46(4):261–268.
  • Hershey AD, Powers SW, L-b VA, et al., Development of a questionnaire to assess disability of migraine in children. Neurology. 57(11): 2034–2039. 2001.
  • Orr SL, Turner A, Kabbouche MA, et al. Predictors of short-term prognosis while in pediatric headache care: an observational study. Headache. 2019;59(4):543–555.
  • Wöber-Bingöl C, Wöber C, Uluduz D, et al. The global burden of headache in children and adolescents – developing a questionnaire and methodology for a global study. J Headache Pain. 2014;15(1):86.
  • Lipton RB, Manack A, Ricci JA, et al. Prevalence and burden of chronic migraine in adolescents: results of the chronic daily headache in adolescents study (C-dAS. Headache. 2011;51(5):693–706.
  • Sasmaz T OA, Bugdayci SE, Buğdaycı R, et al. The prevalence of episodic and chronic migraine in children and adolescents. Eur J Neurol. 2013;20(1):95–101.
  • Reidy BL, Riddle EJ, Powers SW, et al. Clinic-based characterization of continuous headache in children and adolescents: comparing youth with chronic migraine to those with new daily persistent headache. Cephalalgia. 2020;40(10):1063–1069.
  • Kernick D, Reinhold D, Campbell JL. Impact of headache on young people in a school population. Br J Gen Pract. 2009;59(566):678–681.
  • Torres-Ferrus M, Vila-Sala C, Quintana M, et al., Headache, comorbidities and lifestyle in an adolescent population (The TEENs study). Cephalalgia. 39(1): 91–99. 2019.
  • Abu-Arafeh I, Callaghan M. Short migraine attacks of less than 2 h duration in children and adolescents. Cephalalgia. 2004;24(5):333–338.
  • Dasari VR, Clark AJ, Boorigie ME, et al. The influence of lifestyle factors on the burden of pediatric migraine. J Pediatr Nurs. 2021;57:79–83.
  • Eidlitz-Markus T, Gorali O, Haimi-Cohen Y, et al. Symptoms of migraine in the paediatric population by age group. Cephalalgia. 2008;28(12):1259–1263.
  • Eidlitz-Markus T, Haimi-Cohen Y, Zeharia A. Vomiting and migraine-related clinical parameters in pediatric migraine. Headache. 2017;57(6):899–907.
  • Neut D, Fily A, Cuvellier JC, et al. The prevalence of triggers in paediatric migraine: a questionnaire study in 102 children and adolescents. J Headache Pain. 2012;13(1):61–65.
  • Solotareff L, Cuvellier JC, Duhamel A, et al. Trigger factors in childhood migraine: a prospective clinic-based study from North of France. J Child Neurol. 2017;32(8):754–758.
  • Termine C, Ferri M, Livetti G, et al. Migraine with aura with onset in childhood and adolescence: long-term natural history and prognostic factors. Cephalalgia. 2010;30(6):674–681.
  • Hernandez-Latorre MA, Roig M. Natural history of migraine in childhood. Cephalalgia. 2000;20(6):573–579.
  • Esposito M, Gallai B, Parisi L, et al. Maternal stress and childhood migraine: a new perspective on management. Neuropsychiatr Dis Treat. 2013;9:351–355.
  • Smirni D, Carotenuto M. Pediatric chronic migraine severity and maternal stress. Pediatr Rep. 2021;13(4):576–582.
  • Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343–349.
  • Buse DC, Loder EW, Gorman JA, et al., Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American migraine prevalence and prevention (AMPP) study. Headache. 53(8): 1278–1299. 2013.
  • Vetvik KG, MacGregor EA. Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Lancet Neurol. 2017;16(1):76–87.
  • Bolay H, Ozge A, Saginc P, et al. Gender influences headache characteristics with increasing age in migraine patients. Cephalalgia. 2015;35(9):792–800.
  • Pavlovic JM, Akcali D, Bolay H, et al. Sex-related influences in migraine. J Neurosci Res. 2017;95(1–2):587–593.
  • Slater S, Crawford MJ, Kabbouche MA, et al. Effects of gender and age on paediatric headache. Cephalalgia. 2009;29(9):969–973.
  • Fonseca E, Torres-Ferrús M, Gallardo VJ, et al., Impact of puberty in pediatric migraine: a pilot prospective study. J Clin Neurol. 16(3): 416–422. 2020.
  • Tarantino S, Papetti L, Di Stefano A, et al. Anxiety, depression, and body weight in children and adolescents with migraine. Front Psychol. 2020;11:530911. PMID: 33192771; PMCID: PMC7655930.
  • Eidlitz-Markus T, Haimi-Cohen Y, Zeharia A. Association of pediatric obesity and migraine with comparison to tension headache and samples from other countries. J Child Neurol. 2015;30(4):445–450.
  • Hershey AD, Powers SW, Nelson TD, et al. Obesity in the pediatric headache population: a multicenter study. Headache. 2009;49(2):170–177.
  • Ornello R, Ripa P, Pistoia F, et al. Migraine and body mass index categories: a systematic review and meta-analysis of observational studies. J Headache Pain. 2015;16:27.
  • Farello G, Ferrara P, Antenucci A, et al. The link between obesity and migraine in childhood: a systematic review. Ital J Pediatr. 2017;43(1):27.
  • Schwedt TJ, Sahai-Srivastava S, Murinova N, et al. Determinants of pain interference and headache impact in patients who have chronic migraine with medication overuse: results from the MOTS trial. Cephalalgia. 2021;41(10):1053–1064.
  • Park HK, Chu MK, Oh SY, et al. Interim analysis of the registry for load and management of medication overuse headache (RELEASE): a multicenter, comprehensive medication overuse headache registry. Cephalalgia. 2021:3331024211057184. https://doi.org/10.1177/03331024211057184. Epub ahead of print. PMID: 34786971.
  • Sacco S, Lampl C, Maassen van den Brink A, et al. Burden and attitude to resistant and refractory migraine: a survey from the European headache federation with the endorsement of the European Migraine & headache alliance. J Headache Pain. 2021 May 18;22(1):39.
  • van Hoogstraten Ws, MaassenVanDenBrink A, van Hoogstraten WS. The need for new acutely acting antimigraine drugs: moving safely outside acute medication overuse. J Headache Pain. 2019;20(1):54. PMID: 31096904.
  • Chiappedi M, Balottin U. Medication overuse headache in children and adolescents. Curr Pain Headache Rep. 2014;18(4):404.
  • Kossof EH, Mankad DN. Medication-overuse headache in children: is initial preventive therapy necessary? J Child Neurol. 2006;21(1):45–48.
  • Breslau N, Davis GC, Schultz LR, et al., Joint 1994 wolff award presentation. migraine and major depression: a longitudinal study. Headache. 34(7): 387–393. 1994.
  • Breslau N, Schultz LR, Stewart WF, et al. Headache and major depression: is the association specific to migraine? Neurology. 2000;54(2):308–313.
  • Galli F, Caputi M, Gallucci M, et al. Headache and psychological disorders in children and adolescents: a cross-generational study. Minerva Pediatrics. 2017;69(4):231–238.
  • Amouroux R, Rousseau-Salvador C, Pillant M, et al. Longitudinal study shows that depression in childhood is associated with a worse evolution of headaches in adolescence. Acta Paediatr. 2017;106(12):1961–1965.
  • Robberstad L, Dyb G, Hagen K, et al. An unfavorable lifestyle and recurrent headaches among adolescents The HUNT Study. Neurology. 2010;75(8):712–717.
  • Raucci U, Boni A, Evangelisti M, et al. Lifestyle modifications to help prevent headache at a developmental age. Front Neurol. 2021;11:618375. PMID: 33603708; PMCID: PMC7884344.
  • Bektaş Ö, Uğur C, Gençtürk ZB, et al. Relationship of childhood headaches with preferences in leisure time activities, depression, anxiety and eating habits: a population-based, cross-sectional study. Cephalalgia. 2015;35(6):527–537.
  • Guidetti V, Dosi C, Bruni O. The relationship between sleep and headache in children: implications for treatment. Cephalalgia. 2014;34(10):767–776.
  • Gelfand AA, Pavitt S, Ross AC, et al. Later high school start time is associated with lower migraine frequency in adolescents. Headache. 2021;61(2):343–350.
  • Eidlitz-Markus T, Haimi-Cohen Y, Steier D, et al. Effectiveness of nonpharmacologic treatment for migraine in young children. Headache. 2010;50(2):219–223.
  • Faedda N, Cerutti R, Verdecchia P, et al. Behavioral management of headache in children and adolescents. J Headache Pain. 2016;17(1):80, PMID–27596923.
  • Fisher E, Heathcote L, Palermo TM, et al. Systematic review and meta-analysis of psychological therapies for children with chronic pain. J Pediatr Psychol. 2014;39(8):763–782. PMCID: PMC4148613.
  • Orr SL, Kabbouche MA, Horn PS, et al. Predictors of first-line treatment success in children and adolescents visiting an infusion center for acute migraine. Headache. 2018;58(8):1194–1202.
  • Hamalainen ML, Hoppu K, Valkeila E, et al. Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study. Neurology. 1997;48(1):103–107.
  • Wang PR, Lopez R, Seballos SS, et al. Management of migraine in the emergency department: findings from the 2010–2017 national hospital ambulatory medical care surveys. Am J Emerg Med. 2021;41:40–45.
  • Richer L, Billinghurst L, Linsdell MA, et al. Drugs for the acute treatment of migraine in children and adolescents. Cochrane Database Syst Rev. 2016;4. https://doi.org/10.1002/14651858.CD005220.pub2. CD005220.
  • Flake ZA, Linn BS, Hornecker JR. Practical selection of antiemetics in the ambulatory setting. Am Fam Physician. 2015;91(5):293–296.
  • Pradeep R, Nemichandra SC, Harsha S, et al. Migraine disability, quality of life, and its predictors. Ann Neurosci. 2020;27(1):18–23.
  • Powers SW, Coffey CS, Chamberlin LA, et al. Trial of amitriptyline, topiramate, and placebo for pediatric migraine. N Engl J Med. 2017;376(2):115–124.
  • Oskoui M, Pringsheim T, Billinghurst L, et al. Practice guideline update summary: pharmacologic treatment for pediatric migraine prevention: report of the guideline development, dissemination, and implementation subcommittee of the american academy of neurology and the american headache society. Headache. 2019;59(8):1144–1157.
  • Kroner JW, Hershey AD, Kashikar-Zuck SM, et al. Cognitive behavioral therapy plus amitriptyline for children and adolescents with chronic migraine reduces headache days to ≤4 per month. Headache. 2016;56(4):711–716.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.